Subscribe to RSS
Please copy the URL and add it into your RSS Feed Reader.
https://www.thieme-connect.de/rss/thieme/en/10.1055-s-00035024.xml
Download PDF
Thromb Haemost 1995; 74(01): 246-252
DOI: 10.1055/s-0038-1642685
DOI: 10.1055/s-0038-1642685
Colloquium
Disorders Causing Thrombocytopenia
Platelet Transfusion
Authors
Further Information
Publication History
Publication Date:
26 July 2018 (online)
-
References
- 1 BCSH. Guidelines for platelet transfusions. Transfusion Medicine 1992; 2: 311-318
- 2 Seghatchian MJ, Brozovic B. An overview of current trends in platelet preparation storage and transfusion. Blood Coagulation and Fibrinolysis 1992; 3: 617-620
- 3 Williamson LM. Clinical aspects of platelet transfusion. Blood Coagulation and Fibrinolysis 1992; 3: 643-646
- 4 Kirkley SA, Blumberg N. Use of single donor platelets. Blood Reviews 1994; 8: 142-147
- 5 Pietersz RN, Loos JA, Reesink HW. Platelet concentrates stored in plasma for 72 hours at 22°C prepared from buffy coats of citrate’phosphate ’ dextrose blood collected in quadruple bag saline’adenine’glucose mannitol system. Vox Sang 1985; 49: 81-85
- 6 Keegan T, Heaton A, Holme S. Paired comparison of platelet concentrates prepared from platelet rich plasma and buffy coats using a new technique with luIn and 51Cr. Transfusion 1992; 32: 113-120
- 7 Fratantoni JC. The platelet storage lesion possible role of plasticizer. Blood Cells 1992; 18: 435-440
- 8 Mitchell SG, Hawker RJ, Turner VS, Hesslewood SR, Harding LK. Effect of agitation on the quality of platelet concentrates. Vox Sang 1994; 67: 160-165
- 9 Hogman CF. New trends in the preparation and storage of platelets. Transfusion 1992; 32: 3-5
- 10 Rock G, Svensson SD, Adams GA. Platelet storage in a plasma free medium. Transfusion 1985; 25: 551-556
- 11 Holme S. Effect of Additive solutions on platelet biochemistry. Blood Cells 1992; 18: 421-430
- 12 Murphy MF, Waters AM. Platelettransfusions the problem of refractoriness Blood Reviews. 1990; 4: 16-24
- 13 Kickler T, Kennedy SD, Braine HG. AUoimmunisation to platelet specific antigens on glycoproteins Ilb/IIIa and Ib/IX in multiply transfused thrombocytopenic patients. Transfusion 1990; 30: 622-625
- 14 Stack G, Snyder EL. Cytokine generation in stored platelet concentrates. Transfusion 1994; 34: 20-25
- 15 Anderson KC, Weinstein HJ. Transfusion –associated graft–versus–host disease. New Eng J Med 1990; 323: 315-321
- 16 Department of Health. Guidelines for the Blood Transfusion Services in the United Kingdom. 1992. HMSO; London:
- 17 Sniecinski I, O’Donnell MR, Nowicki B, Hill LR. Prevention of refractoriness and HLA-alloimmunisation using filtered blood products. Blood 1988; 71: 1402-1407
- 18 Sweeney JD, Holme S, Moroff G. Storage of apheresis platelets after gamma radiation Transfusion. 1994; 34: 779-783
- 19 Hogman CF, Gong J, Eriksson L, Hambraeus A, Johansson CS. White cells protect donor blood against bacteria contamination. Transfusion 1991; 31: 620-626
- 20 Heal JM, Cohen HJ. Do white cells in stored blood components reduce the likelihood of post-transfusion bacterial sepsis?. Transfusion 1991; 31: 581-583
- 21 Murphy S, Rebulla P, Bertolini F, Holme S, Moroff G, Snyder E. In vitro assessment of the quality of stored platelet concentrates. Transfusion Medicine Reviews 1994; 8: 29-36
- 22 White JG. Ultrastractural changes in stored platelets. Blood Cells 1992; 18: 461-475
- 23 Sims PJ, Favoni EM, Wiedmar T, Shattil SJ. Complement proteins C5b-9 cause release of membrane vesicles from the platelet surface that are enriched in the membrane receptor for coagulation factor Va and express prothrombinase activity. J Biol Chem 1988; 263: 18205-18209
- 24 Brozovic B, Seghatchian MJ, McShine RL. The use of mean platelet volume forevaluation of quality of platelet concentrates. Blood Coagulation and Fibrinolysis 1992; 3: 629-631
- 25 Bellhouse MA, Ross I, Entwistle CC, Bellhouse SJ. Optical measurement of the viability of stored human platelets. Optics Laser Technol 02/1985; 27-30
- 26 Owens M, Holme S, Heaton A, Sawyer S, Cardinali S. Post-transfusion recovery of function of 5-day stored platelet concentrates. Brit J Haematol 1992; 80: 539-544
- 27 Snyder EL, Ezekowitz MD, Malech HL. In vitro characteristics and in vivo viability of platelets contained in granulocyte-platelet apheresis concentrate. Transfusion 1987; 27: 10-14
- 28 Adelman B, Michelson AD, Handin RI, Ault KA. Evaluation of glycoprotein lb by fluorescence flow cytometry. Blood 1985; 66: 423-427
- 29 Bode AP, Knupp CL. Effect of cold storage on platelet glycoprotein lb and vesiculation. Transfusion 1994; 34: 690-696
- 30 Rivera J, Sanchey-Roig MJ, Rosillo MC, Moraleda JM, Vicente V. Stability of glycoproteins Ib/IX and Ilb/IIIa during preparation and storage of platelet concentrates. Vox Sang 1994; 67: 166-171
- 31 Bode AP, Norris TT. The use of inhibitors of platelet activation of protease activity in platelet concentrates stored for transfusion. Blood Cells 1992; 18: 361-380
- 32 Johnson EJ, Mackie IJ, Machin SJ, Brozovic B. Preservation of platelet function in cryopreserved platelet concentrates with protacyclin. Clin and Lab Haematol 1984; 6: 141-144
- 33 Baumann MA, Menitove JE, Aster RH, Anderson T. Urgent treatment of idiopathic thrombocytopenic purpura with single dose gammaglobulin infusion followed by platelet transfusion. Am Intern Med 1986; 104: 808-809
- 34 Caen JP. Glanzmann’s thrombasthenia. Clinical Haematology 1989; 2: 609-625
- 35 Freireich EJ. Effectiveness of platelet transfusion in leukaemia and aplastic anaemia. Transfusion 1966; 6: 50-54
- 36 Higby DJ, Cohen E, Holland JF J, Sinks L. The prophylactic treatment of thrombocytopenic leukaemic patients with platelets A double blind study. Transfusion 1974; 14: 440-446
- 37 Slichter SJ, Harker LA. Thrombocytopenia Mechanisms and Management. Clin Haematol 1978; 7: 523-531
- 38 Gaydos LA, Freireich EJ, Mantel N. The quantitative relation between platelet count and haemorrhage in patients with acute leukaemia. New Eng J Med 1962; 266: 905-909
- 39 McGrath K, Bertram JF, Houghton S, Boothman J, Manderson JA, Minchinton R. Amphotericin-B induced injury in stored human platelets. Transfusion 1992; 32: 46-80
- 40 Gmur J, Burger J, Schanz U, Fehr J, Schaffner A. Safety of stringent prophylactic platelet transfusion policy for patients with acute leukaemia. The Lancet 1991; 338: 1223-1226
- 41 Kelsey HC. An audit of the use of platelet concentrates in the prophylaxis of thrombocytopenic haemorrhage in a large haematology unit. Blood Coagulation and Fibrinolysis 1992; 3: 647-649
- 42 Bishop JF, Matthews K, Yuen K, McGrath K, Wolf M, Szer J. The definition of refractoriness to platelet transfusions. Transfusion Medicine 1992; 2: 35-41
- 43 Bishop JF, McGrath K, Wolf MM, Matthews JP, Deluise TT, Holdsworth R, Yeun K, Veale M, Whiteside MG, Cooper H, Szer J. Clinical factors influencing the efficacy of pooled platelet transfusions. Blood 1988; 71: 383-387
- 44 Godeau B, Fromont P, Seror T, Duedari N, Bierling P. Platelet alloimmunisation after multiple transfusions A prospective study of 50 patients. Br J Haematol 1992; 81: 395-400
- 45 Christie DJ, von Buren N, Lennon SS, Putnam JL. Vancomycin dependent antibodies associated with thrombocytopenia and refractoriness to platelet transfusion in patients with leukaemia. Blood 1990; 75: 518-523
- 46 O’Connell B, Lee EJ, Schiffer CA. The value of 10 minute post-transfusion platelet counts. Transfusion 1988; 28: 66-67